BACKGROUND: Persons with acute HIV infection contribute disproportionately to HIV transmission. The identification of these persons is a critical public health challenge. We developed targeted approaches for detecting HIV RNA in persons with negative serological tests. METHODS: Persons undergoing publicly funded HIV testing in North Carolina between October 2002 and April 2005 were included in this cross-sectional study. We used logistic regression to develop targeted testing approaches. We also assessed simple approaches based on clinic type and geography. Algorithm development used persons with recent HIV infection, determined by a detuned enzyme-linked immunosorbent assay. Validation used persons with acute HIV infection, identified with an HIV RNA pooling procedure. RESULTS: Among 215 528 eligible persons, 232 persons had recent HIV infection and 44 had acute HIV infection. A combination of five indicators (testing site, sexual preference, sex with a person with HIV infection, county HIV incidence, and race) identified 92% of recent infections when testing 50% of the population. In validation among persons with acute HIV infection, this indicator combination had sensitivities of 98% in years 1 and 2 and 88% in year 3. A simple combination of testing site and county performed nearly as well [development (recent infections): sensitivity = 95%; validation (acute infections): sensitivity = 86% in years 1 and 2; 81% in year 3; cut-off established for testing 50% of population.] CONCLUSION: Acute HIV infection can be identified accurately using targeted testing. Simple approaches for identifying the types of clinics and geographical areas where infections are concentrated may be logistically feasible and cost-efficient.
BACKGROUND:Persons with acute HIV infection contribute disproportionately to HIV transmission. The identification of these persons is a critical public health challenge. We developed targeted approaches for detecting HIV RNA in persons with negative serological tests. METHODS:Persons undergoing publicly funded HIV testing in North Carolina between October 2002 and April 2005 were included in this cross-sectional study. We used logistic regression to develop targeted testing approaches. We also assessed simple approaches based on clinic type and geography. Algorithm development used persons with recent HIV infection, determined by a detuned enzyme-linked immunosorbent assay. Validation used persons with acute HIV infection, identified with an HIV RNA pooling procedure. RESULTS: Among 215 528 eligible persons, 232 persons had recent HIV infection and 44 had acute HIV infection. A combination of five indicators (testing site, sexual preference, sex with a person with HIV infection, county HIV incidence, and race) identified 92% of recent infections when testing 50% of the population. In validation among persons with acute HIV infection, this indicator combination had sensitivities of 98% in years 1 and 2 and 88% in year 3. A simple combination of testing site and county performed nearly as well [development (recent infections): sensitivity = 95%; validation (acute infections): sensitivity = 86% in years 1 and 2; 81% in year 3; cut-off established for testing 50% of population.] CONCLUSION:Acute HIV infection can be identified accurately using targeted testing. Simple approaches for identifying the types of clinics and geographical areas where infections are concentrated may be logistically feasible and cost-efficient.
Authors: J S Koopman; J A Jacquez; G W Welch; C P Simon; B Foxman; S M Pollock; D Barth-Jones; A L Adams; K Lange Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1997-03-01
Authors: Jonathan M Pincus; Sondra S Crosby; Elena Losina; Erin R King; Colleen LaBelle; Kenneth A Freedberg Journal: Clin Infect Dis Date: 2003-11-17 Impact factor: 9.079
Authors: Grant N Colfax; Susan P Buchbinder; Peter G A Cornelisse; Eric Vittinghoff; Kenneth Mayer; Connie Celum Journal: AIDS Date: 2002-07-26 Impact factor: 4.177
Authors: Christopher D Pilcher; J Todd McPherson; Peter A Leone; Marlene Smurzynski; Judy Owen-O'Dowd; Amy L Peace-Brewer; Juanita Harris; Charles B Hicks; Joseph J Eron; Susan A Fiscus Journal: JAMA Date: 2002-07-10 Impact factor: 56.272
Authors: Kristine B Patterson; Peter A Leone; Susan A Fiscus; Joann Kuruc; Sandra I McCoy; Leslie Wolf; Evelyn Foust; Del Williams; Joseph J Eron; Christopher D Pilcher Journal: AIDS Date: 2007-11-12 Impact factor: 4.177
Authors: Christopher D Pilcher; George Joaki; Irving F Hoffman; Francis E A Martinson; Clement Mapanje; Paul W Stewart; Kimberly A Powers; Shannon Galvin; David Chilongozi; Syze Gama; Matthew A Price; Susan A Fiscus; Myron S Cohen Journal: AIDS Date: 2007-08-20 Impact factor: 4.177
Authors: Jeb Jones; Martin Hoenigl; Aaron J Siegler; Patrick S Sullivan; Susan Little; Eli Rosenberg Journal: Sex Transm Dis Date: 2017-05 Impact factor: 2.830
Authors: Ann M Dennis; Myron S Cohen; Katherine B Rucinski; Sarah E Rutstein; Kimberly A Powers; Dana K Pasquale; Sam Phiri; Mina C Hosseinipour; Gift Kamanga; Dominic Nsona; Cecilia Massa; Irving F Hoffman; Audrey E Pettifor; William C Miller Journal: Clin Infect Dis Date: 2019-08-16 Impact factor: 9.079
Authors: Kimberly A Powers; Azra C Ghani; William C Miller; Irving F Hoffman; Audrey E Pettifor; Gift Kamanga; Francis Ea Martinson; Myron S Cohen Journal: Lancet Date: 2011-07-16 Impact factor: 79.321
Authors: M Kumi Smith; Sarah E Rutstein; Kimberly A Powers; Sarah Fidler; William C Miller; Joseph J Eron; Myron S Cohen Journal: J Acquir Immune Defic Syndr Date: 2013-07 Impact factor: 3.731
Authors: JoAnn D Kuruc; Anna B Cope; Lynne A Sampson; Cynthia L Gay; Rhonda M Ashby; Evelyn M Foust; Myra Brinson; John E Barnhart; David Margolis; William C Miller; Peter A Leone; Joseph J Eron Journal: J Acquir Immune Defic Syndr Date: 2016-01-01 Impact factor: 3.731
Authors: Angela B Hutchinson; Pragna Patel; Stephanie L Sansom; Paul G Farnham; Timothy J Sullivan; Berry Bennett; Peter R Kerndt; Robert K Bolan; James D Heffelfinger; Vimalanand S Prabhu; Bernard M Branson Journal: PLoS Med Date: 2010-09-28 Impact factor: 11.069
Authors: Jeanne M Marrazzo; Carlos del Rio; David R Holtgrave; Myron S Cohen; Seth C Kalichman; Kenneth H Mayer; Julio S G Montaner; Darrell P Wheeler; Robert M Grant; Beatriz Grinsztejn; N Kumarasamy; Steven Shoptaw; Rochelle P Walensky; Francois Dabis; Jeremy Sugarman; Constance A Benson Journal: JAMA Date: 2014 Jul 23-30 Impact factor: 56.272